Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with localised prostate cancer that a medical team has determined is suitable for a specific type of targeted radiation treatment called SBRT.
- People who have artificial hip replacements on both sides that have been labelled as safe or conditionally safe for use near MRI machines.
- People who are reasonably active and able to carry out daily activities, as assessed by a standard medical scale (ECOG score of 2 or below).
- People who have signed a form agreeing to take part in the trial.
- People aged 18 years or older.
Who may not be able to join:
- People whose body size is too large to fit inside the MRI scanner used in this trial.
- People whose hip replacements have been labelled as unsafe for use near MRI machines.
- People who cannot have an MRI scan for any reason, including: severe claustrophobia (fear of enclosed spaces) that cannot be managed with sedation; certain implanted electronic devices such as pacemakers, heart defibrillators, deep brain stimulators, or cochlear implants that are labelled as MRI unsafe (devices labelled as safe or conditionally safe are not a reason to be excluded); or metal fragments in the eye or surgical clips in the brain.
- People who have serious ongoing health conditions that could interfere with the trial, such as significant liver or heart problems.
- People who would be unable to follow the trial procedures, for example due to language barriers, psychological conditions, or dementia.
- The researchers running this trial, their family members, or people who work for or depend on them.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Matthias Guckenberger, Prof. Dr. med., University of Zurich
Phone: +41442553566
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MR-informed online adaptive definitive SBRT for localized prostate cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.